Showing results (161-170 of 265) with videos related to
Sort By:
Pageof 27
Journal of Thoracic Disease|March 14, 2025
Thoracic autonomic nervous system surgery current application-a survey among members of the European Society of Thoracic SurgeonsFederico Raveglia, Marialuisa Lugaresi, Jozsef Furak, et al.Pathology Oncology Research : POR|January 6, 2020
Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In VivoMarcell Baranyi, Dominika Rittler, Eszter Molnár, et al.European Journal of Cancer (Oxford, England : 1990)|December 13, 2025
Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung)Kristof Cuppens, Marcel Wiesweg, Paul Baas, et al.Scientific Reports|January 5, 2017
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasisZoltan Lohinai, Thomas Klikovits, Judit Moldvay, et al.Frontiers in Cell and Developmental Biology|April 8, 2022
Nintedanib and Dasatinib Treatments Induce Protective Autophagy as a Potential Resistance Mechanism in MPM CellsLuca Hegedüs, Kata D Szücs, Matthias Kudla, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 14, 2005
Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertensionSoni Pullamsetti, Ladislau Kiss, Hossein Ardeschir Ghofrani, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|March 27, 2025
Succinate aggravates pulmonary fibrosis through the succinate/SUCNR1 axisRishi Rajesh, Agnes Anna Mooslechner, Hannah Schweighofer, et al.Scientific Reports|June 14, 2024
C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapyCedric Richlitzki, Marcel Wiesweg, Martin Metzenmacher, et al.Clinical Immunology (Orlando, Fla.)|September 10, 2019
Expression pattern of co-inhibitory molecules on CMV-specific T-cells in lung transplant patientsVasiliki Bessa, Ming Sun, Maike Meier, et al.Cancer & Metabolism|April 1, 2025
Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylationAnna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.Pageof 27